嘉必优生物技术（武汉）股份有限公司关于第二期以集中竞价交易方式回购公司股份的进展公告

Group 1 - The company has approved a second phase of share repurchase using its own funds and special loans, with a total repurchase amount between RMB 15 million and RMB 30 million, and a maximum repurchase price of RMB 25.00 per share, valid for up to 12 months from the board's approval date [1] - The maximum repurchase price was adjusted to RMB 24.80 per share effective July 10, 2025, due to the implementation of the 2024 annual equity distribution [2] - The maximum repurchase price was further adjusted to RMB 35.00 per share effective September 9, 2025, following a board resolution [2] Group 2 - As of November 30, 2025, the company has repurchased a total of 1,060,573 shares, representing 0.63% of the total share capital, with a total transaction amount of RMB 27,921,296.05, and the highest and lowest transaction prices being RMB 28.58 and RMB 23.52 per share, respectively [3] - The company will continue to make repurchase decisions based on market conditions and will fulfill its information disclosure obligations regarding the progress of the share repurchase [4]